Showing 13,241 - 13,260 results of 47,311 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((fold decrease) OR (mean decrease)) ))', query time: 0.98s Refine Results
  1. 13241
  2. 13242
  3. 13243
  4. 13244
  5. 13245
  6. 13246

    TXNIP gene expression in LN of individual RM and sorted cell populations from WT BAC and vCD200 N.S. infection groups. by Ryan Douglas Estep (8399376)

    Published 2020
    “…Error bars denote standard deviation, and a dashed line indicates 2-fold change value. The difference in decreased <i>TXNIP</i> expression in CD20+ cells was found to be significantly different between WT BAC and vCD200 N.S. infection groups by unpaired <i>t</i>-test (*, <i>p</i> = 0.0369).…”
  7. 13247
  8. 13248

    Transient expression of HIF1α(PP) inhibited intracranial tumor growth. by Hyunsung Choi (727224)

    Published 2015
    “…Tumor volumes, plotted in a log scale, decreased significantly from HIF1α(PP) in reference to β-gal. …”
  9. 13249
  10. 13250
  11. 13251
  12. 13252
  13. 13253

    Structure–Activity Studies of 1<i>H</i>‑Imidazo[4,5‑<i>c</i>]quinolin-4-amine Derivatives as A<sub>3</sub> Adenosine Receptor Positive Allosteric Modulators by Lucas B. Fallot (14106171)

    Published 2022
    “…Although having low Caco-2 permeability and high plasma protein binding, hydrophobic 2-cyclohept-4-enyl-<i>N</i>-3,4-dichlorophenyl, MRS7788 <b>18</b>, and 2-heptan-4-yl-<i>N</i>-4-iodophenyl, MRS8054 <b>39</b>, derivatives were orally bioavailable in rat. 2-Heptan-4-yl-<i>N</i>-3,4-dichlorophenyl <b>14</b> and 2-cyclononyl-<i>N</i>-3,4-dichlorophenyl <b>20</b> derivatives and <b>39</b> greatly enhanced Cl-IB-MECA-stimulated [<sup>35</sup>S]GTPγS binding <i>E</i><sub>max</sub>, with only <b>12b</b> trending toward decreasing the agonist EC<sub>50</sub>. A feasible route for radio-iodination at the <i>p-</i>position of a 4-phenylamino substituent suggests a potential radioligand for allosteric site binding. …”
  14. 13254

    Structure–Activity Studies of 1<i>H</i>‑Imidazo[4,5‑<i>c</i>]quinolin-4-amine Derivatives as A<sub>3</sub> Adenosine Receptor Positive Allosteric Modulators by Lucas B. Fallot (14106171)

    Published 2022
    “…Although having low Caco-2 permeability and high plasma protein binding, hydrophobic 2-cyclohept-4-enyl-<i>N</i>-3,4-dichlorophenyl, MRS7788 <b>18</b>, and 2-heptan-4-yl-<i>N</i>-4-iodophenyl, MRS8054 <b>39</b>, derivatives were orally bioavailable in rat. 2-Heptan-4-yl-<i>N</i>-3,4-dichlorophenyl <b>14</b> and 2-cyclononyl-<i>N</i>-3,4-dichlorophenyl <b>20</b> derivatives and <b>39</b> greatly enhanced Cl-IB-MECA-stimulated [<sup>35</sup>S]GTPγS binding <i>E</i><sub>max</sub>, with only <b>12b</b> trending toward decreasing the agonist EC<sub>50</sub>. A feasible route for radio-iodination at the <i>p-</i>position of a 4-phenylamino substituent suggests a potential radioligand for allosteric site binding. …”
  15. 13255
  16. 13256
  17. 13257
  18. 13258
  19. 13259

    The association of diabetic retinopathy with metabolic syndrome. by Lu Gao (44114)

    Published 2016
    “…When patients were grouped according to the number of detected components of the metabolic syndrome, the percentage of patients with DR increased linearly with the increasing number of components in their respective groups (14.3%, 38.9%, 49.1%, 61.4%, 83.3%, respectively), whereas, the percentage of patients without DR decreased with the increasing number of components (85.7%, 61.1%, 50.9%, 38.6%, 16.7%, respectively) (Pearson χ<sup>2</sup> = 9.938, P = 0.037). …”
  20. 13260